BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16006573)

  • 1. Influence of age on cervical cancer survival in Japan.
    Ioka A; Tsukuma H; Ajiki W; Oshima A
    Jpn J Clin Oncol; 2005 Aug; 35(8):464-9. PubMed ID: 16006573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of male breast cancer patients: a population-based study in Osaka, Japan.
    Ioka A; Tsukuma H; Ajiki W; Oshima A
    Jpn J Clin Oncol; 2006 Nov; 36(11):699-703. PubMed ID: 17012302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of self-reported cervical cancer screening and impact on cervical cancer mortality in Austria.
    Vutuc C; Haidinger G; Waldhoer T; Ahmad F; Breitenecker G
    Wien Klin Wochenschr; 1999 May; 111(9):354-9. PubMed ID: 10407996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer survival trends in Osaka, Japan: the influence of age and stage at diagnosis.
    Ito Y; Ohno Y; Rachet B; Coleman MP; Tsukuma H; Oshima A
    Jpn J Clin Oncol; 2007 Jun; 37(6):452-8. PubMed ID: 17635966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
    van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in stomach cancer survival in Osaka, Japan: analyses using relative survival model.
    Sato N; Ito Y; Ioka A; Tanaka M; Tsukuma H
    Jpn J Clin Oncol; 2009 Oct; 39(10):690-4. PubMed ID: 19687052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in cervical cancer survival in Europe, 1983-1994: a population-based study.
    Bielska-Lasota M; Inghelmann R; van de Poll-Franse L; Capocaccia R;
    Gynecol Oncol; 2007 Jun; 105(3):609-19. PubMed ID: 17399766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in the early detection of cervix cancer from the viewpoint of the Saarland cancer register].
    Brenner H; Wiebelt H; Ziegler H
    Geburtshilfe Frauenheilkd; 1990 Apr; 50(4):304-9. PubMed ID: 2358181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation therapy for cervical cancer in the elderly.
    Ikushima H; Takegawa Y; Osaki K; Furutani S; Yamashita K; Kawanaka T; Kubo A; Kudoh T; Nishitani H
    Gynecol Oncol; 2007 Nov; 107(2):339-43. PubMed ID: 17707075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screen-detected invasive cervical carcinoma and its clinical significance during the introduction of organized screening.
    Herbert A; Anshu ; Gregory M; Gupta SS; Singh N
    BJOG; 2009 May; 116(6):854-9. PubMed ID: 19371308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Are analyses of cytological cervix smears from young women more harmful than beneficial?].
    Skjeldestad FE; Hagen B; Hagmar B; Iversen OE; Juvkam KH; Steen R; Thoresen S; Hareide B
    Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1782-5. PubMed ID: 17599128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States.
    Wu X; Matanoski G; Chen VW; Saraiya M; Coughlin SS; King JB; Tao XG
    Cancer; 2008 Nov; 113(10 Suppl):2873-82. PubMed ID: 18980291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of cervical cancer in women age sixty and over.
    Fox KV; Shah CA; Swisher EM; Garcia RL; Mandel LS; Gray HJ; Swensen RE; Goff BA
    Gynecol Oncol; 2008 Apr; 109(1):53-8. PubMed ID: 18255127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of inequalities in cervical cancer stage at diagnosis and survival in New Zealand.
    Priest P; Sadler L; Sykes P; Marshall R; Peters J; Crengle S
    Cancer Causes Control; 2010 Feb; 21(2):209-14. PubMed ID: 19847659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S; Morrell S; Zuo Y; Baker D
    J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethnic differences in survival among Pacific Island patients diagnosed with cervical cancer.
    Robison SW; Dietrich CS; Person DA; Farley JH
    Gynecol Oncol; 2002 Feb; 84(2):303-8. PubMed ID: 11812091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications for primary and secondary exenterations in patients with cervical cancer.
    Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
    Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer incidence in the United States by area of residence, 1998 2001.
    Benard VB; Coughlin SS; Thompson T; Richardson LC
    Obstet Gynecol; 2007 Sep; 110(3):681-6. PubMed ID: 17766618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socioeconomic status and cervical cancer survival among older women: findings from the SEER-Medicare linked data cohorts.
    Coker AL; Du XL; Fang S; Eggleston KS
    Gynecol Oncol; 2006 Aug; 102(2):278-84. PubMed ID: 16434087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.